Psychosocial Assessment of Patients Undergoing Bone Marrow Transplant and Its Correlation   with Transplant Outcome

Munazza Nabi Awan; Nighat  Shahbaz; Irsa  Hidayat; Sahla  Riaz; Hira  Tariq; Saima Humayun  Toor

doi:10.51253/pafmj.v75i6.12223

Authors

Munazza Nabi Awan Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi/ National University of Medical Sciences (NUMS) Pakistan
Nighat Shahbaz Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi/ National University of Medical Sciences (NUMS) Pakistan
Irsa Hidayat Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi/ National University of Medical Sciences (NUMS) Pakistan
Sahla Riaz Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi/ National University of Medical Sciences (NUMS) Pakistan
Hira Tariq Department of Biostatician, Armed Forces Bone Marrow Transplant Centre, Rawalpindi/ National University of Medical Sciences (NUMS) Pakistan
Saima Humayun Toor Department of Hematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi/ National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v75i6.12223

Keywords:

Bone marrow transplantation, Disease-free survival, Psychosocial factors, Readmissions, Survival

Abstract

Objective: To look at how the psychosocial factors impact outcomes of bone marrow transplant in transplant recipients, in a resource-limited country.

Study Design: Cross-sectional study.

Place and Duration of Study: Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan from Jul 2022 to Jun 2023.

Methodology: A total of 30 adult patients were included by non-probability Convenience Sampling, who underwent bone marrow transplant. Transplant outcome was measured in terms of hospital readmission rate, overall survival and disease-free survival at 90 days post-transplant. Pre-transplant Psychosocial assessment was done at time of admission for transplant prior to start of conditioning chemotherapy using Psychosocial Assessment of Candidates for Transplantation scale (PACT).

Results: Out of total, 21 patients (70.0%) were male and 9 patients (30.0%) were female. Median age at time of transplant was 30.50(IQR: 20.75- 49.25) years. At follow up of 3 months OS was 87% (n=26, mean OS days= 81.20+4.14) and DFS was 83.0% (n=25, mean DFS days=69.04+4.66). Average duration of hospital stay was 20.53+ 9.58 day. All patients were low risk on HCT CI score. Higher Readmission rates were seen in patients (n=4, 13%) with lower PACT scores in domain of social stability. Higher final PACT score was significantly associated with improved OS and DFS.

Conclusion: We concluded that patient’s psychosocial status can impact post HSCT outcome. Post transplant outcome and hospital readmission rate can be improved with good psychosocial support. Therefore, we recommend psychosocial assessment before ...

Downloads

Download data is not yet available.

References

Janicsák H, Ungvari GS, Gazdag G. Psychosocial aspects of hematopoietic stem cell transplantation. World J Transplant 2021; 11(7): 263. https://doi.org/10.5500/wjt.v11.i7.263

2. Thilges SR., Bolton C, Mumby PB. Pretransplant psychological assessment for stem cell treatment. J Health Serv Psychol 2018; 44(1): 117-124. https://doi.org/10.1007/bf03544671

3. Hong S. Pre-transplant psychosocial assessment and outcomes of allogeneic hematopoietic cell transplantation in adults. Blood 2016; 128(22): 3552.

https://doi.org/10.1182/blood.v128.22.3552.3552

4. Randall J, Kayser K. Pre-Transplant Psychosocial Assessment practices: a national survey of transplant centers. Biol Blood Marrow Transplant 2020 26(3): S204.

https://doi.org/10.1016/j.bbmt.2019.12.698

5. Richardson DR, Huang Y, McGinty HL, Elder P, Newlin J, Kirkendall C, et al. Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients. Bone Marrow Transplant 2018; 53(11): 1418-1427.

https://doi.org/10.1038/s41409-018-0118-4

6. Solh, M.M., et al., The Transplant Evaluation Rating Scale predicts overall survival after allogeneic hematopoietic stem cell transplantation. Blood advances, 2020. 4(19): p. 4812-4821.

https://doi.org/10.1182/bloodadvances.2020002204

7. Harashima S. Psychosocial Assessment of Candidates for Transplantation scale (PACT) and survival after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2019; 54(7): 1013-1021.

https://doi.org/10.1038/s41409-018-0371-6

8. Hong S, Rybicki L, Corrigan D, Dabney J, Hamilton BK, Kalaycio M, et al. Psychosocial Assessment of Candidates for Transplant (PACT) as a tool for psychological and social evaluation of allogeneic hematopoietic cell transplantation recipients. Bone Marrow Transplant 2019; 54(9): 1443-1452.

https://doi.org/10.1038/s41409-019-0455-y

9. Liang Y, Wang H, Niu M, Zhu X, Cai J, Wang X et al. Longitudinal Analysis of the Relationships Between Social Support and Health-Related Quality of Life in Hematopoietic Stem Cell Transplant Recipients. Cancer Nurs 2019;42(3): 251-257. https://doi.org/10.1097/ncc.0000000000000616

10. Ali N. Haematopoietic Stem Cell Transplant Trends in Pakistan: Activity Survey from Pakistan Bone Marrow Transplant Group. J Transplant 2023; 2023(1): 1-6.

https://doi.org/10.1155/2023/8865364

11. Wiener L, Sannes TS, Randall J, Lahijana S, Applebaum AJ, Gray TF, et al. Psychosocial assessment practices for hematopoietic stem cell transplantation: a national survey study. Bone Marrow Transplant 2023; 58(12): 1314-1321.

https://doi.org/10.1038/s41409-023-02087-0

12. Thakar MS, Broglie L, Logan B, Artz A, Bunin N, Burroughs LM, et al. The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. Blood 2019; 133(7): 754-762.

https://doi.org/10.1182/blood-2018-09-876284

13. Spring L. Risk factors for readmission after allogeneic hematopoietic stem cell transplantation and impact on overall survival. Biol Blood Marrow Transplant 2015; 21(3): 509-516.

https://doi.org/10.1016/j.bbmt.2014.11.682

14. Sora F, Chiusolo P, Laurenti L, Innocenti I, Autore F, Giammarco S, et al. Days Alive Outside Hospital and Readmissions in Patients Undergoing Allogeneic Transplants from Identical Siblings or Alternative Donors. Mediterr J Hematol Infect Dis 2020; 12(1): e2020055. https://doi.org/10.4084/mjhid.2020.055

15. Maher OM, Silva JG, Huh WW, Cuglievan B, DePombo A, Kebriaei P, et al. Etiologies and Impact of Readmission Rates in the First 180 Days After Hematopoietic Stem Cell Transplantation in Children, Adolescents, and Young Adults. J Pediatr Hematol Oncol 2017; 39(8): 609-613.

https://doi.org/10.1097/mph.0000000000000898

16. Johnson PC, Markovitz NH, Gray TF, Bhatt S, Nipp RD, Ufere N, et al. Association of Social Support With Overall Survival and Healthcare Utilization in Patients With Aggressive Hematologic Malignancies. J Natl Compr Canc Netw 2021: 1-7.

https://doi.org/10.6004/jnccn.2021.7033

17. Mishkin AD, Shapiro PA, Reshef R, Lopez-Pintado S, Mapara MY. Standardized Semi-structured Psychosocial Evaluation before Hematopoietic Stem Cell Transplantation Predicts Patient Adherence to Post-Transplant Regimen. Biol Blood Marrow Transplant 2019; 25(11):2222-2227.

https://doi.org/10.1016/j.bbmt.2019.06.019

18. Ice LL, Bartoo GT, McCullough KB, Wolf RC, Dierkhising RA, Mara KC, et al. A Prospective Survey of Outpatient Medication Adherence in Adult Allogeneic Hematopoietic Stem Cell Transplantation Patients. Biol Blood Marrow Transplant. 2020; 26(9): 1627-1634. https://doi.org/10.1016/j.bbmt.2020.05.020